All stock lists
OSR Health, Inc. (OSRH)
United States · Delayed Price · Currency is USD
Healthcare · Biotechnology
$0.14+$0.04 (+40.00%)
Insider Score
––Not scored
OSRH Insider Score
Insiders here have filed 6 Form 4s in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
OSRH Stock Insider Trading Activity
OSRH stock’s insider trading shows no open-market insider trades by company insiders over the last 6 months.
Not enough price history.
Insider Trading Activity (Form 4 Filings)
An insider trade occurs when an individual that has non-public information about a company buys or sells shares of that company’s stock. Examples of insiders include a company’s executive officers (CEO, CFO, COO), its board of directors, and its major shareholders. Insiders are required to submit their trading activity to the SEC through Form 4 filings.
Filters
| Form 4 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Hwang Kuk Hyoun CEO | Award | 1,173,697 | $0.23 | $266.66K | New | 1,173,697 | Oct 29, 2026 | — | Form 4 |
| Kim Yeiseok COO | Award | 293,422 | $0.23 | $66.67K | 1188% | 318,121 | Oct 29, 2026 | — | Form 4 |
| Bang Gihyoun CFO | Award | 440,137 | $0.23 | $100.00K | New | 440,137 | Oct 29, 2026 | — | Form 4 |
| Cho Joong Myung Director | Award | 120,000 | — | — | New | 120,000 | Oct 29, 2026 | — | Form 4 |
| Barberis Alcide Director | Award | 120,000 | — | — | New | 120,000 | Oct 29, 2026 | — | Form 4 |
| Mah Seng Chin Director | Award | 120,000 | — | — | New | 120,000 | Oct 29, 2026 | — | Form 4 |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.
